Investigating the effect of sweet almond on symptoms of COVID 19

Phase 3

Recruiting

Conditions: Condition 1: COVID-19. Condition 2: Cough. Condition 3: Shortness of breath. Condition 4: Fever.
COVID-19
Cough
Shortness of breath
Fever, unspecified
U07.1
R06.02
R50.9

Registration Number: IRCT20180712040446N2

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

All patients with corona (confirmed by test or CT) who have one of the clinical manifestations (shortness of breath and cough).
Patients hospitalized

Exclusion Criteria

Any allergies to Almonds sweet or other foods
Patients who ate Almonds sweet regularly
Inability to take medication orally
Diabetic patients
Taking Opioid medications
Use of Antitussive products
Suffering from other respiratory diseases
Hospitalization in the intensive care unit

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity shortness of breath. Timepoint: At the beginning of the study, 3 and 6 days after the start using product. Method of measurement: Dyspnoea-12 questionnaire.;Severity of cough. Timepoint: At the beginning of the study, 3 and 6 days after the start using product. Method of measurement: Leicester Cough Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Sleep Quality. Timepoint: At the beginning of the study, 3 and 6 days after the start of product consumption. Method of measurement: Petersburg Sleep Quality Questionnaire.